Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma

Objective: Chronic subdural hematoma (CSDH) is a common form of intracranial hemorrhage with a substantial recurrence rate. Atorvastatin may reduce CSDH via its anti-inflammatory and pro-angiogenesis effects, but its effectiveness for preventing recurrent CSDH has never been explored. We hypothesize...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hua, Luo, Zhengxiang, Liu, Zhongkun, Yang, Jian, Kan, Shifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923224/
https://www.ncbi.nlm.nih.gov/pubmed/27445673
http://dx.doi.org/10.3389/fnins.2016.00303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923224/
https://www.ncbi.nlm.nih.gov/pubmed/27445673
http://dx.doi.org/10.3389/fnins.2016.00303

Ejemplares similares